Life Planning Partners’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Life Planning Partners’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-304	Closed	-$213	–	265
2023 Q4	$213	Buy	+304	New	+$176	﹤0.01%	253

Other funds holding DMK

CPA

Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return

OPTFSNA

Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Life Planning Partners's DMK Position: Q1 2024 in Review

Life Planning Partners sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 304 shares — an estimated $213 sold.

Life Planning Partners first reported a position in DMK in Q4 2023 and held it in 1 quarter. The position peaked at $213 in Q4 2023. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

Life Planning Partners reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
Life Planning Partners sold 304 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $213.
Life Planning Partners first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2023 and held it in 1 quarter.
Life Planning Partners's DMK Pharmaceuticals Corporation Common Stock position peaked at $213 in Q4 2023.
3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Life Planning Partners's 13F filing for Q1 2024, filed 2 May 2024.